Lateral flow reader market seen growing to $2.44 billion by 2030

The lateral flow reader market is projected to rise from $1.46 billion in 2025 to $2.44 billion by 2030, driven by home healthcare, point-of-care testing and digital health integration. North America led in 2025, while Asia-Pacific is expected to be the fastest-growing region.

Why it matters: - The lateral flow reader market is moving deeper into routine diagnostics as care shifts away from hospitals and into homes, clinics and point-of-care settings. - Demand is rising for faster test interpretation, better connectivity and more quantitative results. - The market’s expansion signals more spending on diagnostic tools that support infectious disease screening, chronic care and remote monitoring.

What happened: - The Business Research Company said the global lateral flow reader market was worth $1.46 billion in 2025 and is expected to reach $1.62 billion in 2026. - The firm projects the market will climb to $2.44 billion by 2030. - The report puts the 2025-2026 growth rate at 11.1% and the 2026-2030 growth rate at 10.9%. - North America held the largest market share in 2025. - Asia-Pacific is forecast to be the fastest-growing region over the next several years.

The details: - Lateral flow readers are analytical devices that use optical detection to read lateral flow assays. - The devices can deliver qualitative, semi-quantitative or quantitative results. - The systems detect substances such as pathogens and biomarkers on test strips. - Reported applications include medical testing, environmental monitoring and food safety assessments. - Historic growth was driven by rapid diagnostic testing demand, infectious disease screening, greater laboratory adoption, portable devices and clinical research use. - Future growth drivers include decentralization of diagnostic services, connected point-of-care technologies, home-based testing, digital health integration and improved optical detection. - Emerging trends include quantitative lateral flow readers, smartphone-based diagnostics, AI-enhanced result interpretation, broader point-of-care use and stronger data management features. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - New 2026 report features include market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated graphics and tables. - The company also listed a free sample report and the full report on its website: free sample report and the full market report.

Between the lines: - Home healthcare is becoming a bigger driver because it gives patients a more convenient and lower-cost way to get monitoring and treatment. - The report ties that shift to older adults and people with chronic illnesses who need frequent testing outside traditional facilities. - In July 2024, the Australian Health and Welfare Institute said the number of older Australians using home care services had risen by more than 200,000 over the past decade. - The same data showed the population receiving at-home care increased from 57,000 to 258,000, a 357% rise. - That trend supports demand for readers that can interpret results quickly without a clinical visit.

What's next: - The market is expected to benefit from continued growth in home testing and point-of-care diagnostics. - More adoption of connected devices and digital health platforms could make lateral flow readers more useful in remote and decentralized care. - Smartphone-linked and AI-assisted systems are likely to shape product development as buyers look for faster and more usable testing workflows. - Asia-Pacific’s faster growth suggests future market gains may come increasingly from outside North America.

The bottom line: - Lateral flow readers are moving from a niche diagnostic tool to a broader platform for rapid, connected testing, with growth likely to stay strong through 2030.